OMX30 1 573 0,3%  OMXH25 3 802 -0,4%  OMXC20 927 -0,8%  Dow 20 548 -0,2%  Nas 5 442 0,0%  EUR 9,6121 -0,5%  USD 8,8644 -1,5%  Olja 52,2 0,3%  Guld 1 276 -0,7% 

Eli Lilly and Aktie

81,93USD -0,01USD -0,01%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Eli Lilly and

2016 2017e 2018e 2019e 2020e
Utdelning 2,04 2,09 2,17 2,27 2,48
Direktavkastning (i %) 2,76 2,40 2,48 2,60 2,84
PE-tal 21,04 21,24 19,89 17,63 15,27
Resultat/aktie 3,52 4,11 4,39 4,95 5,72

Nyheter om Eli Lilly and Co.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Eli Lilly and Co.

ytterligare analyser

Eli Lilly and Peer Group

Bayer 105,20
0,8%
Eli Lilly and 81,93
0,0%
GlaxoSmithKline 15,66
0,2%
Merck 61,89
-1,1%
Merck 103,00
-0,5%
MorphoSys 51,51
-0,6%
Novartis 73,30
0,1%
Pfizer 33,63
-0,3%
STADA 64,45
0,0%
pagehit

Lägg till instrument

Vad tycker du?

Profil Eli Lilly and Co.till bolagsprofilen

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. It operates through the Human Pharmaceutical Products and Animal Health segments. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing, and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular, and other. The Animal health segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The Other Pharmaceuticals products include anti-infectives, primarily Vancocin and Ceclor, and other miscellaneous pharmaceutical products and services. Its products are distributed through wholesalers that serve pharmacies, physicians and other health care professionals, and hospitals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Realtidskurs Eli Lilly and Co.

Bid
81,92
USD
Ask
81,93
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Eli Lilly and Co. i USDPUSH CHART

Kurs 81,93 USD -0,01 -0,01 %
Kurstid 21:59:59
Datum 21.04.2017
Öppning 81,88
Gårdagen 81,93
Dagshögsta 82,23
Dagslägsta 81,69
52 v. högsta 86,71
52 v. lägsta 63,70
52 v. perf.
Volym (Antal) 218 690
Börsvärde (SEK) 818,45 Mrd
Börsen
Kurs för 81,93 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 726,26 SEK.

Till aktien Eli Lilly and

Ticker
ISIN US5324571083
Index BX Swiss - USA, S&P 100, NYSE US 100, S&P 500

Eli Lilly and Nyckeltal

Börsvärde i SEK 818,45 Mrd
Free float % 88,41
Antal aktier mio. 1 103,35
Cashflow/aktie i lokal valuta 4,03
Bokvärde/aktie i lokal valuta 13,76
60 dagar vola 21,41
PBV 5,38

Eli Lilly and Historiska kurser

2017-04-21 81,93 218 690
2017-04-20 81,94 213 236
2017-04-19 80,88 513 261
2017-04-18 81,21 602 548
2017-04-17 82,42 683 004

Aktier i samma industri med bättre 1 års perf.

Amylin Pharmaceuticals Inc. 264,9 %
Patheon Inc Restricted Voting Cash Settlement At USD 9.32 A Sh 173,5 %
Array BioPharma Inc. 171,7 %
CV Therapeutics Inc. 169,1 %
Medarex Inc. 123,7 %